Cloxacillin Stragen: Uses, Dosage & Side Effects

What Is Cloxacillin Stragen and What Is It Used For?

Cloxacillin Stragen contains the active substance cloxacillin, which belongs to a class of antibiotics known as penicillinase-stable penicillins (also referred to as isoxazolyl penicillins or anti-staphylococcal penicillins). This class of antibiotics was developed in the 1960s specifically to address a growing clinical problem: the emergence of staphylococcal bacteria that had developed resistance to standard penicillin by producing an enzyme called penicillinase (a type of beta-lactamase). This enzyme breaks the beta-lactam ring of conventional penicillins, rendering them inactive. Cloxacillin, along with related isoxazolyl penicillins such as flucloxacillin and dicloxacillin, was engineered with a bulky side chain that sterically protects the beta-lactam ring from enzymatic hydrolysis.

The mechanism of action of cloxacillin is fundamentally the same as all beta-lactam antibiotics: it is bactericidal and works by inhibiting bacterial cell wall synthesis. Specifically, cloxacillin binds to penicillin-binding proteins (PBPs) on the inner surface of the bacterial cell membrane. These PBPs are transpeptidase enzymes essential for the cross-linking of peptidoglycan strands, which form the structural backbone of the bacterial cell wall. When cloxacillin blocks these enzymes, the bacterium cannot maintain its cell wall integrity during growth and division. This leads to osmotic instability, cell lysis, and ultimately bacterial death. Because mammalian cells do not possess peptidoglycan cell walls, cloxacillin is selectively toxic to bacteria.

Cloxacillin has a relatively narrow antibacterial spectrum compared to broad-spectrum penicillins such as amoxicillin or ampicillin. Its primary activity is directed against Gram-positive aerobic bacteria, particularly Staphylococcus aureus (both penicillinase-producing and non-producing strains) and Staphylococcus epidermidis. It also retains activity against streptococci (including Streptococcus pyogenes and Streptococcus pneumoniae) and some anaerobic bacteria. Importantly, cloxacillin is not effective against methicillin-resistant Staphylococcus aureus (MRSA), which has acquired resistance through alteration of the PBP target (PBP2a/PBP2’), rendering all isoxazolyl penicillins ineffective regardless of their beta-lactamase stability.

Cloxacillin Stragen is indicated for the treatment of infections caused by penicillinase-producing staphylococci. The approved clinical indications include:

• Skin and soft tissue infections: Cellulitis, wound infections, surgical site infections, and deep-seated soft tissue abscesses caused by susceptible staphylococci. These are among the most common indications for parenteral cloxacillin.
• Endocarditis: Infective endocarditis (infection of the heart valves) caused by methicillin-susceptible Staphylococcus aureus (MSSA). Staphylococcal endocarditis is a life-threatening condition requiring prolonged intravenous antibiotic therapy, typically 4–6 weeks.
• Osteomyelitis: Bone infection (osteomyelitis) caused by susceptible staphylococci. This condition often requires extended courses of parenteral antibiotic therapy, sometimes followed by a transition to oral antibiotics.
• Sepsis: Bloodstream infection (bacteremia/sepsis) caused by penicillinase-producing staphylococci. Staphylococcal sepsis is a medical emergency requiring urgent intravenous antibiotic administration.

In clinical practice, cloxacillin is often the parenteral anti-staphylococcal penicillin of choice in many European and international settings, while in the United Kingdom, flucloxacillin (a closely related isoxazolyl penicillin) is preferred, and in the United States, nafcillin and oxacillin are more commonly used. All of these agents share the same fundamental mechanism and spectrum of activity, though there are differences in pharmacokinetic properties and side-effect profiles. The choice between these agents is largely determined by regional availability and established clinical guidelines.

What Should You Know Before Taking Cloxacillin Stragen?

Contraindications

There are specific situations where Cloxacillin Stragen must not be used. Understanding these absolute contraindications is essential for safe medication use and to prevent potentially life-threatening adverse reactions.

• Allergy to cloxacillin: Do not receive Cloxacillin Stragen if you have a confirmed hypersensitivity (allergy) to cloxacillin or any of the ingredients in the product.
• Allergy to other penicillins: Patients with a known allergy to any other penicillin-type antibiotic (such as amoxicillin, ampicillin, flucloxacillin, or benzylpenicillin) must not receive cloxacillin due to the high likelihood of cross-reactivity within the penicillin family.
• Allergy to cephalosporins: Patients with a history of severe allergic reactions to cephalosporins (such as cefazolin, cephalexin, or ceftriaxone) should generally avoid cloxacillin. Although the rate of true cross-reactivity between penicillins and cephalosporins is relatively low (approximately 1–2%), the consequences of cross-reactivity can be severe, and caution is warranted, particularly in patients with a history of anaphylaxis.

Warnings and Precautions

Before receiving Cloxacillin Stragen, you should inform your healthcare provider about the following conditions and circumstances:

• Impaired kidney function: Cloxacillin is primarily eliminated through the kidneys. In patients with reduced renal function, the drug may accumulate to higher levels than intended, increasing the risk of adverse effects. Of particular concern, penicillin-class antibiotics (including cloxacillin) can cause encephalopathy (brain dysfunction) when they accumulate to high concentrations, especially in patients with renal impairment. Symptoms of encephalopathy may include fever, stiff neck, headache, difficulty moving the arms or legs, speech problems, and confusion. If any of these symptoms occur, contact your healthcare team immediately.
• Risk of encephalopathy: As with all penicillin antibiotics, administration of cloxacillin—particularly at high doses or in patients with impaired renal function—can cause an altered mental state due to encephalopathy. This rare but serious complication has been documented with various beta-lactam antibiotics and is related to the neurotoxic potential of high penicillin concentrations crossing the blood-brain barrier. Dose adjustment and monitoring of drug levels may be warranted in at-risk patients.
• Sodium content: Cloxacillin Stragen contains a clinically significant amount of sodium. Each 1 g vial contains approximately 52.9 mg sodium (2.6% of the WHO-recommended maximum daily intake of 2 g for adults), while each 2 g vial contains approximately 105.8 mg sodium (5.3%). At maximum recommended daily doses, the total sodium intake from the medication alone can reach 634.8 mg (31.7% of maximum daily intake). This should be taken into account for patients on sodium-restricted diets, particularly those with heart failure, hypertension, or chronic kidney disease. Discuss with your doctor if you are on a low-sodium diet and will be receiving cloxacillin for an extended period.
• Antibiotic-associated colitis: Like all broad-spectrum antibiotics, cloxacillin can alter the normal intestinal flora, potentially leading to overgrowth of Clostridioides difficile and the development of pseudomembranous colitis. This condition can range from mild diarrhea to severe, life-threatening inflammation of the colon. If you develop severe or persistent diarrhea during or after treatment with cloxacillin, inform your doctor immediately.
• Superinfection: Prolonged use of any antibiotic can lead to overgrowth of non-susceptible organisms, including fungi. Regular monitoring and appropriate measures should be taken if superinfection occurs.

Pregnancy and Breastfeeding

Long clinical experience with cloxacillin and related isoxazolyl penicillins suggests a low risk of harmful effects on pregnancy, the fetus, or the newborn child. Penicillins as a class are generally considered among the safest antibiotics for use during pregnancy, and they are widely used when clinically indicated. However, as with all medications during pregnancy, cloxacillin should only be used when the potential benefit to the mother justifies any potential risk to the fetus. If you are pregnant or planning to become pregnant, consult your doctor before receiving this medication.

Small amounts of cloxacillin pass into breast milk. At therapeutic doses, the amount transferred to the nursing infant is generally considered too low to have a harmful effect. However, there is a theoretical possibility of effects on the infant’s gastrointestinal and oral flora, and small amounts of antibiotic in breast milk could increase the risk of sensitization (development of allergy) in the infant. If your breastfed infant develops diarrhea, skin rash, or oral thrush while you are receiving cloxacillin, inform your doctor or pediatrician.

Driving and Operating Machinery

Cloxacillin Stragen is not expected to affect the ability to drive or operate machinery under normal circumstances. However, given the rare possibility of neurological side effects (such as encephalopathy, confusion, or dizziness), patients should assess their own condition before engaging in activities that require full alertness. If you experience any symptoms that could impair your concentration or coordination, refrain from driving or operating machinery until those symptoms have fully resolved.

How Does Cloxacillin Stragen Interact with Other Drugs?

Drug interactions can affect how a medication works or increase the risk of side effects. Because Cloxacillin Stragen is administered in a hospital or clinical setting, your healthcare team will typically review your complete medication list before starting treatment. However, it is essential that you inform your doctor, nurse, or pharmacist about all medications you are currently taking, have recently taken, or might take, including prescription drugs, over-the-counter medicines, and herbal supplements.

The following drug interactions are of particular clinical importance when receiving cloxacillin:

Major Interactions

Minor Interactions and Additional Considerations

Beyond the major interactions described above, several additional pharmacological considerations apply when using cloxacillin:

• Other antibiotics: Cloxacillin may be used in combination with other antibiotics (such as aminoglycosides like gentamicin) for synergistic bactericidal effect in serious staphylococcal infections, particularly endocarditis. However, cloxacillin should not be physically mixed with aminoglycosides in the same infusion solution, as they are chemically incompatible and can inactivate each other. They should be administered through separate intravenous lines or at separate times.
• Compatible infusion solutions: Cloxacillin is compatible with water for injections, 0.9% sodium chloride solution, 5% glucose solution, and Ringer-acetate solution. It must not be mixed with other medications in the same infusion bag or syringe.
• Laboratory test interference: Like other penicillins, cloxacillin may cause false-positive results in urine glucose tests that use copper-reduction methods (e.g., Benedict’s reagent, Clinitest). Enzyme-based glucose tests (e.g., glucose oxidase methods) are not affected and should be used instead.

What Is the Correct Dosage of Cloxacillin Stragen?

Cloxacillin Stragen is a hospital-administered medication. The powder must be reconstituted (dissolved in a suitable diluent) before use, and it is given by a healthcare professional as an intravenous (IV) injection, intravenous infusion, or intramuscular (IM) injection. You will not need to calculate or measure the dose yourself. Your doctor will determine the appropriate dose based on the type and severity of infection, your body weight, kidney function, and other clinical factors.

Adults

Children

Elderly

Elderly patients may have age-related decline in kidney function, which can affect the elimination of cloxacillin. Dose adjustment may be necessary in elderly patients with impaired renal function. Your doctor will assess your kidney function (typically through blood tests measuring creatinine clearance or estimated glomerular filtration rate) and adjust the dose accordingly. Elderly patients are also at greater risk for sodium-related complications due to the sodium content of the medication, and for neurological side effects such as encephalopathy.

Missed Dose

Because Cloxacillin Stragen is administered by healthcare professionals in a clinical setting, missed doses are unlikely. If a dose is inadvertently delayed, your healthcare team will adjust the dosing schedule as appropriate. Do not attempt to self-administer this medication. If you have concerns about your dosing schedule, speak with your nurse or doctor.

Overdose

As with all penicillin-class antibiotics, overdosage with cloxacillin can manifest primarily as neurological toxicity. The risk is significantly increased in patients with renal impairment, as reduced kidney function leads to accumulation of the drug to neurotoxic levels. In clinical practice, overdosage is uncommon because the drug is administered by trained healthcare professionals in a controlled environment. If an overdose does occur, management is supportive: discontinuation of the drug, monitoring of vital signs and neurological status, and maintenance of adequate fluid intake and urine output to facilitate renal excretion.

What Are the Side Effects of Cloxacillin Stragen?

Like all medications, Cloxacillin Stragen can cause side effects, although not everyone who receives it will experience them. Side effects are classified by how frequently they occur, following the standard medical convention used internationally:

The side-effect profile of cloxacillin is broadly similar to that of other isoxazolyl penicillins (such as flucloxacillin and dicloxacillin) and penicillins in general. Gastrointestinal disturbances (nausea, diarrhea) are the most commonly reported adverse effects and are usually mild and self-limiting. Phlebitis at the intravenous injection site is a common local reaction that can be minimized by ensuring proper dilution and slow infusion rates. Skin rash may represent either a mild hypersensitivity reaction or a non-allergic rash; any new rash during antibiotic treatment should be reported to your healthcare team for evaluation.

Allergic reactions to penicillins range from mild skin rashes to life-threatening anaphylaxis. True IgE-mediated anaphylaxis to penicillins occurs in approximately 0.01–0.05% of treatment courses but can be fatal if not treated promptly with epinephrine (adrenaline). Patients with a history of penicillin allergy, allergic asthma, hay fever, or urticaria are at higher risk for allergic reactions.

Agranulocytosis is a rare but potentially serious complication that has been reported with penicillinase-stable penicillins. This condition involves a severe reduction in the number of granulocytes (a type of white blood cell essential for fighting infection), leaving the patient highly vulnerable to infections. Symptoms include high fever, sore throat, mouth ulcers, and general malaise. Blood monitoring during prolonged treatment courses can help detect this complication early.

DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a rare but severe drug hypersensitivity reaction that has been reported with various antibiotics including penicillins. It typically presents 2–8 weeks after starting the medication and involves fever, extensive skin rash, facial swelling, lymphadenopathy, eosinophilia, and potentially life-threatening organ involvement (hepatitis, nephritis, pneumonitis). If DRESS syndrome is suspected, the drug should be discontinued immediately and specialist care should be sought.

How Should You Store Cloxacillin Stragen?

Cloxacillin Stragen in its dry powder form does not require any special storage conditions. It should be kept out of the sight and reach of children and should not be used after the expiry date printed on the label and carton (the expiry date refers to the last day of the stated month). In practice, because this medication is administered in a hospital or clinical setting, storage is handled by the pharmacy or nursing staff.

After reconstitution (dissolving the powder in the appropriate diluent), the stability of the solution depends on the diluent used and the storage conditions:

• Water for injections or 0.9% sodium chloride (1 g and 2 g vials): Stable for up to 6 hours at room temperature (25°C) in ambient light, or up to 24 hours at 2–8°C protected from light.
• 5% glucose solution: Stable for up to 6 hours at room temperature (25°C), or up to 24 hours at 2–8°C protected from light.
• Ringer-acetate solution: Stable for up to 12 hours at room temperature (25°C), up to 96 hours at 2–8°C protected from light, or up to 48 hours refrigerated followed by 24 hours at room temperature.

From a microbiological standpoint, the reconstituted solution should ideally be used immediately after preparation. If not used immediately, the storage time and conditions before use are the responsibility of the healthcare professional and should generally not exceed 24 hours at 2–8°C, unless reconstitution and dilution were performed under controlled, validated aseptic conditions. The reconstituted solution should be clear; do not use if it contains visible particles.

Do not dispose of medications via wastewater or household waste. Unused medication and waste should be disposed of in accordance with local requirements for pharmaceutical waste. Your healthcare facility will handle this appropriately.

What Does Cloxacillin Stragen Contain?

Cloxacillin Stragen is a powder for injection/infusion solution. The active substance is cloxacillin, present as cloxacillin sodium. Each vial contains the following:

The product contains no excipients (inactive ingredients). This means the vial contains only cloxacillin sodium and nothing else. The powder is white to off-white in color and is packaged in single-use glass vials sealed with a rubber stopper and aluminum cap, contained within an outer carton. Each carton of 1 g and 2 g vials contains 10 vials.

The sodium content of Cloxacillin Stragen is a relevant consideration, particularly for patients on sodium-restricted diets. At the maximum recommended daily dose, total sodium from the medication alone can contribute up to 634.8 mg sodium per day, equivalent to 31.7% of the WHO-recommended maximum daily intake of 2 g sodium for adults. Patients with conditions such as congestive heart failure, chronic kidney disease, or hypertension who require sodium restriction should have their overall sodium intake monitored during prolonged cloxacillin therapy.

The product is manufactured by MITIM S.r.l. in Brescia, Italy, and marketed by Stragen Nordic A/S. It is available under several brand names including Cloxacillin Stragen, Cloxacillin XGX Pharma, and Cloxacillin Navamedic, though all contain the same active substance and are used for the same clinical indications.